Q: Where did you go to college/graduate school?
I attended Southern Texas University, located in Houston, Texas. Go Tigers!
Q: Where do you live?
I currently live
…
Q: Where did you grow up?
Scranton, PA – home of The Office
Q: Where did you go to college/graduate school?
King’s College; BS Neuroscience and MS Healthcare
…SPONSORED CONTENT
When people consider technology’s role in adapting to pandemic-constrained life, many begrudgingly think about endless hours spent on videoconferences. Yet, pandemic-infused technological innovations also altered our lives in other ways, big and small. For instance, I’ll never go back to wearing “slacks” and wondering what my face looks like with just a mustache. On a much more serious note, millions of Americans lost their lives or fought severe health battles. Others switched careers, relocated, or reconsidered how they wanted to live. In each of these instances, technology, more often than not, played a critical role.
It’s no secret that the pandemic had a devastating effect on health care institutions and front-line workers. At Avita, our covered entity partners bravely faced the one-two punch of evolving patient needs paired with providers leaving the profession in droves. When combined with the ever-changing 340B environment, this means community health organizations must leverage
…
Q: Where did you grow up?
I was born and raised in Northwest Indiana and have lived in the Chicago area for the past 25 years.
Q: Where
…SPONSORED CONTENT
Commencing in the early 1970s, specialty pharmacy was originally intended for patients requiring unique therapies for various conditions. Initially this included mainly infusions for hemophilia, cancer, or malnutrition[i]. Most of these offerings came with high costs (many of which can now be offset by copay assistance programs), and special storage and/or shipping requirements[ii].
Specialty pharmacy has since expanded rapidly, and Merck’s launch of indinavir (Crixivan®) in 1996 marked a significant milestone. As the third approved protease inhibitor for HIV treatment, the launch followed a record setting fast-track FDA approval. The decision to dispense Crixivan® exclusively through Stadtlanders specialty pharmacy[iii] set the tone for the limited distribution networks that we see today.
Between 1970 and 2000, most specialty medications were covered as a medical expense. However, a shift occurred in the early 2000s, with specialty transitioning to the pharmacy benefit. Today,
…SPONSORED CONTENT
Location: Gaylord National Resort & Convention Center
Start your 340B Coalition Summer Conference with the latest developments in the 340B program. Verity Solutions will be hosting a panel discussion at the Gaylord Resort in National Harbor with some of the most respected long-term experts on the 340B program. Join us for an up-to-the-minute report on hot button topics related to the legislative, compliance, and regulatory aspects of the 340B program.
Among the topics to be covered:
Space is limited and only open to 340B covered entities.
Q: Where did you complete your professional training?
I attended the Pharmacy Technician Program at Idaho State University.
Q: Where do you live?
Priest River, Idaho
SPONSORED CONTENT
TIP: To ensure you’re not leaving any 340B dollars behind, assess your ineligible claims to understand if claims are being missed.
SPONSORED CONTENT
The healthcare industry continues to evolve. We see this evolution range from technology advancements and self-serve digital platforms to competing payer coverages and vast access to both acute and maintenance medications. Throughout this evolution, the patient experience and continuity of care are crucial to supporting a patient’s journey throughout the healthcare ecosystem. Here are six ways specialty pharmacies like AllianceRx Walgreens Pharmacy can help ensure the patient experience also evolves:
Q: Where did you grow up?
Dallas, Texas
Q: Where did you go to college/graduate school?
Dallas College – Richland Campus
Q: What are your favorites?
Food:
…*Sign up for news summaries and alerts from 340B Report
